Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases?
- 1 September 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 2 (9), 481-490
- https://doi.org/10.1038/ncprheum0290
Abstract
Ature Clinical Practice Oncology will deliver timely interpretations of key research developments, translating the latest findings into clinical practice. Our Editor-in-Chief and international Advisory Board will ensure comprehensive coverage of topical issues throughout the year, with the highest standards of editorial quality and integrity that are hallmarks of Nature Publishing Group.Keywords
This publication has 57 references indexed in Scilit:
- Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activityAnnals Of The Rheumatic Diseases, 2005
- C1q: Its Functions within the Innate and Adaptive Immune Responses and its Role in Lupus AutoimmunityJournal of Investigative Dermatology, 2005
- Reversal of ongoing proteinuria in autoimmune mice by treatment with C‐reactive proteinArthritis & Rheumatism, 2005
- Do we need new treatment principles for RA patients beyond anti-TNFα medication?Autoimmunity Reviews, 2004
- Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in miceEuropean Journal of Immunology, 2004
- Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C‐reactive protein transgeneArthritis & Rheumatism, 2003
- C1q, Autoimmunity and ApoptosisImmunobiology, 2002
- Significant Elevations in Serum Mannose-Binding Lectin Levels in Patients with Chronic Renal FailureNephron, 2002
- ComplementNew England Journal of Medicine, 2001
- The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritisArthritis & Rheumatism, 2000